Part 1. Introduction

• 1.1 Market Definition
• 1.2 Key Benefit
• 1.3 Market Segment

Part 2. Methodology

• 2.1 Primary
• 2.2 Secondary

Part 3. Executive Summary

Part 4. Market Overview

• 4.1 Introduction
• 4.2 Market Size and Forecast
• 4.3 Market Dynamics
  • 4.3.1 Drivers
  • 4.3.2 Restraints
• 4.4 Impact of COVID-19 Pandemic

Part 5. Global Market for Irritable Bowel Syndrome Treatment by Type

• 5.1 Ibs With Constipation (Ibs-C)
  • 5.1.1 Market Size and Forecast
• 5.2 Ibs With Diarrhea (Ibs-D)
  • 5.2.1 Market Size and Forecast
• 5.3 Mixed-Presentation Ibs (Ibs-M)
  • 5.3.1 Market Size and Forecast

Part 6. Global Market for Irritable Bowel Syndrome Treatment by Product

• 6.1 Eluxadoline
  • 6.1.1 Market Size and Forecast
• 6.2 Linaclotide
  • 6.2.1 Market Size and Forecast
• 6.3 Lubiprostone
  • 6.3.1 Market Size and Forecast
• 6.4 Rifaximin
  • 6.4.1 Market Size and Forecast
• 6.5 Others
  • 6.5.1 Market Size and Forecast

Part 7. Global Market for Irritable Bowel Syndrome Treatment by Distribution Channel

• 7.1 Drug Stores And Retail Pharmacies
  • 7.1.1 Market Size and Forecast
• 7.2 Hospitals’ Pharmacies
  • 7.2.1 Market Size and Forecast
• 7.3 Online Pharmacies
  • 7.3.1 Market Size and Forecast
• 7.4 Others
  • 7.4.1 Market Size and Forecast

Part 8. Global Market for Irritable Bowel Syndrome Treatment by Region

• 8.1 Asia-Pacific
  • 8.1.1 Market Size and Forecast
• 8.2 Europe
  • 8.2.1 Market Size and Forecast
• 8.3 North America
  • 8.3.1 Market Size and Forecast
• 8.4 Middle East And Africa (Mea)
  • 8.4.1 Market Size and Forecast
• 8.5 South America
  • 8.5.1 Market Size and Forecast

Part 9. Key Competitor Profiles

• 9.1 Abbott Laboratories
• 9.2 Allergan plc
• 9.3 Ardelyx, Inc.
• 9.4 Astellas Pharma Inc.
• 9.5 AstraZeneca plc
• 9.6 GlaxoSmithKline plc
• 9.7 Johnson & Johnson
• 9.8 Novartis AG
• 9.9 The Takeda Pharmaceutical Company Limited

*LIST IS NOT EXHAUSTIVE

Part 10. Patent Analysis

• 10.1 Patent Statistics
• 10.2 Regional Analysis
• 10.3 Trends Analysis

DISCLAIMER

ABOUT GEN CONSULTING COMPANY

The global irritable bowel syndrome treatment market is projected to grow at a compound annual growth rate (CAGR) of 8.6% during the forecast period 2021-2027, according to the new report published by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global irritable bowel syndrome treatment market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, company share of market leaders, growth rate and market segments.

The irritable bowel syndrome treatment market is segmented on the basis of type, product, distribution channel, and region. The irritable bowel syndrome treatment market is segmented as below:

By Type:
- IBS with constipation (IBS-C)
- IBS with diarrhea (IBS-D)
- mixed-presentation IBS (IBS-M)

By Product:
- eluxadoline
- linaclotide
- lubiprostone
- rifaximin
- others

By Distribution Channel:
- drug stores and retail pharmacies
- hospitals’ pharmacies
- online pharmacies
- others

By Region:
- region
- Asia-Pacific
- Europe
- North America
- Middle East and Africa (MEA)
- South America

The irritable bowel syndrome treatment industry is characterized by a high level of market share concentration. The market research report covers the analysis of key stake holders of the irritable bowel syndrome treatment market. Some of the leading players profiled in the report include Abbott Laboratories, Allergan plc, Ardelyx, Inc., Astellas Pharma Inc., AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, The Takeda Pharmaceutical Company Limited, among others.
*list is not exhaustive, request free sample to get a complete list of companies

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global irritable bowel syndrome treatment market.
- To classify and forecast the global irritable bowel syndrome treatment market based on type, product, distribution channel, and region.
- To identify drivers and challenges for the global irritable bowel syndrome treatment market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global irritable bowel syndrome treatment market.
- To conduct pricing analysis for the global irritable bowel syndrome treatment market.
- To identify and analyze the profile of leading players operating in the global irritable bowel syndrome treatment market.

Why Choose This Report
- Gain a reliable outlook of the global irritable bowel syndrome treatment market forecasts from 2021 to 2027 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.